Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT Study
Conditions
- Healthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular Disease
Interventions
- DRUG: Low intensity statin
- DRUG: Moderate intensity statin
Sponsor
Yonsei University